|
TB Notes NewsletterReturn to Main Menu - TB Notes 1, 2008
No. 1, 2008
Revision of Technical Instructions for Panel
Physicians
The Division of Global Migration and Quarantine (DGMQ)
has completed the revision of the Technical Instructions for panel
physicians. Since 2005, DGMQ has been working with DTBE to review
scientific literature on overseas pre-immigration medical screening
and develop new algorithms. Input was also solicited from the U.S.
tuberculosis community.
The 2007
Technical Instructions for Tuberculosis Screening and Treatment (TB
TIs) provide a modernized approach to TB screening overseas for
U.S. immigration applicants. For the first time, mycobacterial
cultures will be required for applicants suspected of having TB
disease. Moreover, drug susceptibility testing (DST) on positive
isolates and directly observed therapy (DOT) according to CDC /
American Thoracic Society (ATS) / Infectious Diseases Society of
America (IDSA) standards will be required for applicants with TB
disease. It is expected that implementation of the 2007 TB TIs
should help prevent importation of TB into the United States,
improve U.S. domestic TB control, and increase TB infrastructure
globally.
The 2007 TB TIs were first implemented in April 2007
for the screening of 14,000 Burmese refugees from Thailand who were
to be resettled to the United States. The 2007 TB TIs have also been
recently implemented for all applicants from Mexico and the
Philippines. Global implementation will occur over the next several
years, beginning in priority countries determined by immigration
patterns, refugee resettlements, burden of TB, and U.S. domestic
foreign-born TB case rates.
—Reported by Drew Posey, MD
Div of Global Migration and Quarantine
Last Updated:
07/01/2008
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|
|
Back to Top of Page
If you would like to order any of the DTBE publications please visit the online order form.
You will need Adobe Acrobat Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat Reader.
If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us
in writing or via telephone and we will work with you to make the information available.
Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov
Home | Site Map
| Contact Us
Accessibility
| Privacy Policy Notice |
FOIA
| USA.gov
CDC Home |
Search |
Health Topics A-Z
Centers for Disease Control & Prevention
National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov
|